Comparison of the Use of Vaccines or Drugs against Parasitic Diseases

Authors: H. Al-Khalaifa, A. Al-Nasser

Abstract:

The viewpoint towards the use of drugs or vaccines against avian parasitic diseases is one of the most striking challenges in avian medical parasitology. This includes many difficulties associated with drug resistance and in developing prophylactic vaccines. In many instances, the potential success of a vaccination in controlling parasitic diseases in poultry is well-documented. However, some medical, technical and financial limitations are still paramount. On the other hand, chemotherapy is not very well-recommended due to a number of medical limitations. But in the absence of an effective vaccine, drugs are used against parasitic diseases. This paper sheds light on some the advantages and disadvantages of using vaccination and drugs in controlling parasitic diseases in poultry species. The usage of chemotherapeutic drugs is discussed with some examples. Then, more light will be shed on using vaccines as a potentially effective and promising control tool.

Keywords: Drugs, parasitology, poultry, vaccines.

Digital Object Identifier (DOI): doi.org/10.5281/zenodo.1315919

References:

[1] Morrison, W. I. and F. Tomley, Development of vaccines for parasitic diseases of animals: Challenges and opportunities. Parasite immunology, 2016. 38(12): p. 707-708.
[2] Kumarasingha, R., et al., Anthelmintic activity of selected ethno-medicinal plant extracts on parasitic stages of Haemonchus contortus. Parasites & vectors, 2016. 9(1): p. 187.
[3] Cox, F. E., Modern parasitology: a textbook of parasitology. 1982: Oxford, UK; Blackwell Scientific Publications.
[4] Andrews, K. T., G. Fisher, and T. S. Skinner-Adams, Drug repurposing and human parasitic protozoan diseases. International Journal for Parasitology: Drugs and Drug Resistance, 2014. 4(2): p. 95-111.
[5] Pearson, R. D. and E. L. Hewlett, Pentamidine for the treatment of Pneumocystis carinii pneumonia and other protozoal diseases. Annals of internal medicine, 1985. 103(5): p. 782-786.
[6] Hanboonkunupakarn, B. and N. J. White, The threat of antimalarial drug resistance. Tropical Diseases, Travel Medicine and Vaccines, 2016. 2(1): p. 10.
[7] Leiferman, K. M., et al., Dermal deposition of eosinophil-granule major basic protein in atopic dermatitis: comparison with onchocerciasis. New England Journal of Medicine, 1985. 313(5): p. 282-285.
[8] Hyde, J. E., Molecular parasitology. 1991: Open University Press.
[9] Cheah,P. Y. and White N. J., Antimalarial mass drug administration: ethical considerations. International Health, 2016. 8 (4): p. 235-238.
[10] Alvarado, C., et al., Dietary supplementation with antioxidants improves functions and decreases oxidative stress of leukocytes from prematurely aging mice. Nutrition, 2006. 22(7/8): p. 767-777.
[11] Kumar, S., et al., A multilateral effort to develop DNA vaccines against falciparum malaria. Trends in Parasitology, 2002. 18(3): p. 129-135.
[12] Graves, P., Comparison of the cost-effectiveness of vaccines and insecticide impregnation of mosquito nets for the prevention of malaria. Annals of tropical medicine and parasitology, 1998. 92(4): p. 399-410.
[13] O'Shea, M. K. and H. McShane, A review of clinical models for the evaluation of human TB vaccines. Human vaccines & immunotherapeutics, 2016. 12(5): p. 1177-1187.
[14] Chan, H. T. and H. Daniell, Plant‐made oral vaccines against human infectious diseases—Are we there yet? Plant biotechnology journal, 2015. 13(8): p. 1056-1070.
[15] Muthumani, K., et al., Rapid and long-term immunity elicited by DNA encoded antibody prophylaxis and DNA vaccination against Chikungunya virus. Journal of Infectious Diseases, 2016: p. jiw111.